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INTRODUCTION
Preeclampsia is still one of the major complications
during pregnancy, delivery and post-partum
period. Preeclampsia, one of the causes of death
other than bleeding and infection.1 The effect can
lead to the disruption of maternal and fetal well-
being. Despite considerable progress in the field of
obstetrics and perinatology services for antenatal
and neonatal care, but nonetheless, preeclampsia
remains one of the most common causes of
maternal and perinatal morbidity and mortality.2
Every year nearly 40.000 women, especially in
developing countries die from preeclampsia or
eclampsia. Preeclampsia or eclampsia are the
second leading cause of maternal death in Pakistan.
The prevalence of preeclampsia ranges between
7%-10% of all pregnancies. In the United States,
the incidence was 23.6 cases/1000 pregnancies.
Whereas in the UK the incidence of severe pre-
eclampsia ranges from 5/1000 pregnant women
and 5/10,000 pregnant women in eclampsia. And
the incidence of preeclampsia tends to increase
from year to years.3 In Indonesia, this disorder is
still the top three highest contributors to maternal
mortality after bleeding and infection, with inci-
dence rates varying between 2.1 to 8.5%. The
pathogenesis of preeclampsia until now remains
unclear. Preeclampsia is a disorder characterised
by hypertension and proteinuria occurred > 20
weeks of gestation. Around the world, about 2-3%
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Abstrak
Tujuan: Mengetahui perbandingan kadar 25-hydroxyvitamin D pada
kehamilan normotensif dan preeklamsia berat.
Metode: Penelitian ini merupakan suatu penelitian potong lintang
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of all pregnant women can develop preeclampsia.
This condition is a major cause of maternal and
perinatal morbidity and mortality.3,4
Vitamin D plays an important role in calcium
metabolism, immune system, proliferation and
cell differentiation, the process of infection and
cancer.5,6 Within the last ten years, research on
vitamin D prove that vitamin D effects on concep-
tion, pregnancy and health neonatal.7 Vitamin D
(cholecalciferol) formed by the skin during expo-
sure to sunlight (ultraviolet radiation), and also
absorbed from food. Absorption of cholecalciferol
converted in the liver to 25(OH) cholecalciferol or
25- hydroxyvitamin D (25(OH)D), and then by
1-hydroxylation in the kidney to 1,25 hydroxy-
lase dihydroxycholecalciferol or 1,25(OH)2D3,
most forms active group vitamin D.
Vitamin D receptors are also present in the
placenta. Levels of 1,25(OH)2D3 increases during
pregnancy through increased 1-hydroxylase. The
discovery of the levels of 25(OH)D in maternal and
umbilical cord serum proved that the development
of the placenta and fetus are directly related to
vitamin D intake and sun exposure.8 Levels of
25(OH)D were lower in the first trimester associ-
ated with the incidence of preeclampsia.9 Intake of
vitamin D during early life is required so that the
risk of preeclampsia can be reduced up to 50%
pregnancy.10
Magnus (2001) observed that the incidence of
preeclampsia-related with seasons. The incidence
of preeclampsia is reduced in summer with high
sun exposure.11 Vitamin D deficiency (levels of
25(OH)D <17.5 nmol/l) and insufficiency (levels
of 25(OH)D <50nmol/l) was found in tropical
countries, for example, India and Bangladesh with
high sun exposure.12 Green (2008) investigated the
levels of 25(OH)D in reproductive age women in
Jakarta and Kuala Lumpur, and it showed that
60% reproductive-aged women have vitamin D
insufficiency.
Deficiency of vitamin D (25(OH)D) causes
endothelial dysfunction through the molecular
mechanism. Endothelial dysfunction that occurs in
preeclampsia begins with exposure of the endo-
thelial cell membrane by mediators released as a
result of placental ischemia and hypoxia, among
the products of lipid peroxidation, resulting in
damage of the cell membrane. Disruption of cell
membranes earlier can disturb endothelial
function, and even cause damage to the entire
structure of endothelial cells. As a result of damage
to endothelial cells, the endothelial function as a
mechanical barrier endothelial lost so that leakage
that causes extravasation of fluid into the extra-
vascular intra, in addition to producing endothelial
function and NO PGI2 also decreased, resulting in
vasoconstriction and increased blood pressure.13-15
In addition to the endothelial damage also causes
many other disorders, such as, decreased produc-
tion of prostacyclin, platelet aggregation in areas
of damaged endothelium which will also produce
thromboxane A2. The typical changes in the
glomerular capillaries form of glomerular endo-
theliosis, increased capillary permeability, in-
creased coagulation factors.
There also are found vitamin D (25(OH)D) effect
on trophoblast invasion and angiogenesis when
implantation process, so this is an important factor
in the pathophysiology preeclampsia.5 Many other
studies that try to prove the pathogenesis of
preeclampsia associated with defence vitamin D,
for example regarding the response, oxidative
stress and angiogenesis.13-15
OBJECTIVE
This study was performed to investigate the levels
of 25-hydroxyvitamin D in normotensive preg-
nancy and severe preeclampsia.
METHOD
This research is an analytical cross-sectional study
with t-test to compare the levels of 25-hydroxy-
vitamin D in normotensive pregnant women and
severe preeclampsia. This research was conducted
and evaluated from August 2016 to December
2016 in the Department of Obstetrics and
Gynecology, Faculty of Medicine, Universitas Sam
Ratulangi / Prof. Dr. R.D. Kandou Manado and
hospital networks in Manado to research subjects
who meet the inclusion and exclusion criteria. The
inclusion criteria include pregnant women 20
weeks gestation to term with severe preeclampsia,
superimposed preeclampsia and eclampsia and
willing to participate in research. Exclusion criteria
included pregnant women with chronic hyperten-
sion, heart disease, liver, kidney, diabetes mellitus,
fetal growth retardation, and refuse to join the
study. Subjects consisted of 17 samples and 17
samples of normotensive severe preeclampsia.
After anamnesis, physical examination and have
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informed consent, serum samples were taken from
as many as 5 ccs and put into a sterile sample
container, centrifuged and stored at -20°C and then
processed in Prodia a clinical laboratory method
chemiluminescent immunoassay (CLIA). This study
has also been approved by the Integrated Health
Research Unit (UPKT) Prof. Dr. R.D. Kandou
Manado. Data were analyzed with SPSS version
20.0.
RESULT
In Table 1 shows the subject of research in the
normotensive group most aged 21 to 35 years is
13 people (76.47%), Minahasans many as 14
people (82.36%), job IRT 11 (64.7%), multigravida
as many as 11 people (64.71%) and the wedding
one time as many as 15 people (88.24%). While in
severe preeclampsia group there are at most
ages 21-35 years as many as 9 people (52.94%),
Minahasans 10 (58.83%), job IRT 16 people
(94.12%), multigravida 10 people (58.82%) and
the wedding one time as many as 15 people
(88.24%).
Table 1. Research Subject Characteristics
Characteristics
Normotensive Preeclampsia
n % n %
Age
< 20 years - 0 2 11.76
21-35 years 13 76.47 9 52.94
> 36 years 4 23.53 6 35.30
Ethnic
Minahasa 14 82.36 10 58.83
Sangihe 1 5.88 4 23.53
Gorontalo 1 5.88 1 5.88
Etc 1 5.88 2 11.76
Occupation
Housewife 11 64.7 16 94.12
Private employee 1 5.88 1 5.88
Government employee 4 23.53 - -
Student 1 5.88 - -
Parity
Primigravidity 6 35.29 7 41.18
Multigravidity 11 64.71 10 58.82
Marriage
1 15 88.24 15 88.24
> 1 2 11.76 2 11.76
Table 2. Variable Distribution of Age and Blood Pressure (BP) In normotensive Pregnancy and Severe Preeclampsia
Variable Normotensive Pregnancy(n = 17) Severe Preeclampsia(n = 17) p
Age 31.41  5.455 30.94  9.692 0.863
Systolic BP 122.35  10.326 168.24  14.246 0.000
Diastolic BP 78.82  9.275 108.82  6.002 0.000
Table 3. 25-Hydroxyvitamin DLevels in Normotensive Pregnancy and Severe Preeclampsia
Variable Normotensive Pregnancy(n = 17) Severe Preeclampsia(n = 17) p
Kadar 25-hydroxyvitamin D (ng/ml)
Mean  SD 24.771  6.9567 17.712  3.7513 0.001
Median 24.700 17.500
Highest value 14.8 7.9
Lowest value 40.7 22.4
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From the above table, for the age variable t-test
(mean difference between two independent
variables), it was found there was no significant
difference between the age groups of normo-
tensive and severe preeclampsia group, so it was
concluded there was no correlation between the
incidence of severe preeclampsia with maternal
age. Whereas for the variable systolic blood
pressure and diastolic blood pressure test and the
Mann-Whitney there are significant differences
between the systolic and diastolic blood pressure
in normotensive and severe preeclampsia group, so
it was concluded there is a correlation between the
incidence of severe preeclampsia with systolic and
diastolic blood pressure.
In Table 3, 25-hydroxyvitamin D levels in
pregnancy with normotensive obtained the
highest levels of 40.7 ng/ml and the lowest
levels in normotensive 14.8 ng/ml. As for severe
preeclampsia 25-hydroxyvitamin D levels high of
22.4 ng/ml while 25- hydroxyvitamin D levels low
of 7.9 ng/ml.
By using the t-test (mean difference between two
independent variable), it was concluded that there
are significant differences in vitamin D levels in
each of the normotensive group (24.771  6.9567)
and severe preeclampsia group (17.712  3.7513),
(p = 0.001), meaning that there is a relationship
between the incidence of severe preeclampsia with
blood levels of vitamin D (Table 3 and Figure1).
Shapiro-Wilk normality test showed that the
distribution of data levels of vitamin D in the
normotensive group and Severe Preeclampsia were
normally distributed (p = 0.57 and p = 0.13).
DISCUSSION
The basic characteristics of the study sample
include age, ethnicity, occupation, parity, marriage
with sample number 34 and is divided into two
groups: group with normotensive pregnancy and
severe preeclampsia group. Table 1 can be seen
from the distribution of study subjects based on
the age of the mother is 16 to 46 years. The highest
percentage in the age group 21-35 years both in
the normotensive group as many as 13 people
(76.47%) and severe preeclampsia group were
nine people (52.94%). Followed age > 36 yrs
namely the normotensive group of 4 people
(23.53%) and severe preeclampsia six people
(35.3%). In this study, the Minahasa tribe is the
tribe most studied as many as 14 people in the
normotensive group (82.36%) and ten men in the
severe preeclampsia group (58.83%), because the
study was conducted in the city of Manado, North
Sulawesi where Minahasans a majority interest. In
this study, it was found that the incidence of severe
preeclampsia increases in the productive age and
IRT. This contrasts with research conducted by SQ
Wei et al in June 2012 which reported that there
was no significant difference between preeclamp-
sia and nonpreeclampsia terms of maternal age,
education and ethnicity.5
In this group, the highest percentage obtained
parity characteristics are good multigravida in nor-
motensive group (64.7%) and severe preeclampsia
(58.82%). This is due to the distribution of samples
high in this group. Preeclampsia often occurs at a
young age and primiparous, it is suspected because
of the existence of a mechanism immunology.13,16
In Table 3 shows the relationship of vitamin D
(25(OH)D) in pregnancy normotensive, and severe
preeclampsia in which it was concluded there are
significant differences in the levels of vitamin D
(25(OH)D) in the normotensive and severe pre-
eclampsia, with an average value levels vitamin D
(25(OH)D) in normotensive 24.771  6.9567 ng/ml
while in severe preeclampsia group was 17.712 
3.7513 ng/ml (p = 0.001). This suggests there is a
correlation between levels of vitamin D (25(OH)D)
and the incidence of severe preeclampsia.
Research in Surabaya Hanifa et al. (2015) that
compared 18 women of severe preeclampsia and
18 normotensive women found a significant
difference between levels of vitamin D (25(OH)D)
in the normotensive with severe preeclampsia.
Levels of vitamin (25(OH)D) in normotensive
Figure  1. Graphs the levels of 25-hydroxyvitamin D in
normotensive pregnancy and severe preeclampsia
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(11.7  4.8) compared with severe preeclampsia
(15.9  4.5). The hypothesis about the levels of
vitamin D (25(OH)D) maternal determine the risk
of preeclampsia.18
From several studies reported that a deficiency
of vitamin D (25(OH)D) related to an inflammatory
process due to endothelial dysfunction. Is a layer
of endothelial cells lining the vascular wall facing
the lumen and attached to the subendothelial
tissue consisting of collagen and various glycosa-
minoglycans including fibronectin.17 Formerly con-
sidered that endothelial function is as a structural
barrier between the circulation of the surrounding
tissue, but it is now known that the endothelial
function of regulating vascular tone, prevents
thrombosis, regulate the activity of the fibrinolytic
system, preventing the adhesion of leukocytes and
regulates vascular growth. Issued endothelial vaso-
active substances include nitric oxide (NO) which
is also called endothelial-derived relaxing factor
(EDRF), endothelial-derived hyperpolarising factor
(EDHF), prostacyclin (PGI2), bradykinin, acetyl-
choline, serotonin and histamine. Among other
vasoconstrictor substance endothelin, platelet
activating factor (PAF), angiotensin II, prosta-
glandin H2, thrombin and nicotine. Deficiency of
vitamin D (25(OH)D) causes endothelial dysfunc-
tion through the molecular mechanism. Where the
result of a deficiency of vitamin D (25(OH)D)
causes the release of most of the proinflammatory
factors including the increase in NFkB (nuclear
factor-kB), interleukin-6, a decrease in the vitamin
D receptor, 1-hydroxylase, and calcium levels.
Wherein the calcium associated with vitamin
absorption D.5,20,21 If endothelial impaired in by
many things such as oxidative stress, shear stress
hemodynamic, hypercholesterolemia and exposure
of inflammatory cytokines, the regulatory function
becomes abnormal and is called endothelial
dysfunction.18-21 Deficiency of vitamin D (25(OH)D)
in pregnancy predisposes proinflammatory
response and oxidative stress resulting in endo-
thelial dysfunction that is the hallmark of
preeclampsia. There also are found vitamin D (25
(OH)D) effect on trophoblast invasion and angio-
genesis when implantation process, so this
is an important factor in the pathophysiology
preeclampsia.5 Several studies have also reported
a deficiency of vitamin D (25(OH)D) and the risk
of preeclampsia. Marya et al. suggest that the
intake of calcium and vitamin D can lower blood
pressure, thereby reducing the incidence of
preeclampsia. Other researchers such as Haugen
et al. (2009) Haryana et al. (2012), Abdulbari
(2013), Dharma et al. (2005) also suggests the
same result.14,15,19-21
CONCLUSION
From this study, it can be concluded that the
obtained 25-hydroxyvitamin D levels were lower
in patients with severe preeclampsia. The results
of the analysis of the relationship of 25-hydroxy-
vitamin D levels with the incidence of severe
preeclampsia in getting that blood levels of 25-
hydroxyvitamin D a pregnant woman is associated
with severe preeclampsia.
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